✅ Product Benefits
-
Dual-action combo therapy
Combines a long‑acting beta₂‑agonist (Salmeterol) with an inhaled corticosteroid (Fluticasone) to manage chronic asthma and COPD effectively -
Convenient twice‑daily dosing
One capsule inhaled morning and evening via dry powder device maintains bronchodilation and inflammation control -
Appropriate for adolescents (≥12 yrs) & adults
Ideal for patients uncontrolled on corticosteroids alone or requiring combination therapy -
Improves lung function & reduces exacerbations
Enhances airflow, decreases symptoms and flare-ups over monotherapy -
Well-established dosing guidelines
Standard adult regimen: 50 µg/250 µg twice daily; max dosing up to 50/500 µg BID as needed. -
Accessible pricing & packaging
Pack of 48 capsules -
Safety and usage precautions
Not for acute attack relief. Patients should rinse mouth post-inhalation to prevent candidiasis; taper dose gradually and monitor for side effects (hoarseness, thrush, headache)
Customer questions & answers
Customer reviews
0 out of 5